世界のウイルスベクター製造市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Viral Vector Manufacturing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5941
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ウイルスベクター製造のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アデノウイルスベクター、アデノ随伴ウイルスベクター、レトロウイルスベクター、レンチウイルスベクター、その他）、用途別市場規模（遺伝子治療、ワクチン）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ウイルスベクター製造の市場動向
・企業の競争状況、市場シェア
・ウイルスベクター製造の種類別市場規模（アデノウイルスベクター、アデノ随伴ウイルスベクター、レトロウイルスベクター、レンチウイルスベクター、その他）
・ウイルスベクター製造の用途別市場規模（遺伝子治療、ワクチン）
・ウイルスベクター製造の北米市場規模2016-2027（アメリカ、カナダ）
・ウイルスベクター製造のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ウイルスベクター製造のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ウイルスベクター製造の中南米市場規模2016-2027（メキシコ、ブラジル）
・ウイルスベクター製造の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（BioReliance、Cobra Biologics、Oxford BioMedica、UniQure、FinVector、MolMed、MassBiologics、FUJIFILM Diosynth Biotechnologies、Lonza、Biovian、Thermo Fisher Scientific (Brammer Bio)）
・結論

Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells.
Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, baculovirus, etc. are being routinely used in life sciences research and are finding applications in vaccinology and novel drug delivery approaches.

Market Analysis and Insights: Global Viral Vector Manufacturing Market
The global Viral Vector Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Viral Vector Manufacturing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Viral Vector Manufacturing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Viral Vector Manufacturing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Viral Vector Manufacturing market.

Global Viral Vector Manufacturing Scope and Market Size
Viral Vector Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vector Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Adenoviral Vectors
Adeno-associated Viral Vectors
Retroviral Vectors
Lentiviral Vectors
Other

Segment by Application
Gene Therapy
Vaccinology

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
FUJIFILM Diosynth Biotechnologies
Lonza

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Manufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Adenoviral Vectors
1.2.3 Adeno-associated Viral Vectors
1.2.4 Retroviral Vectors
1.2.5 Lentiviral Vectors
1.2.6 Other
1.3 Market by Application
1.3.1 Global Viral Vector Manufacturing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Gene Therapy
1.3.3 Vaccinology
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Viral Vector Manufacturing Market Perspective (2016-2027)
2.2 Viral Vector Manufacturing Growth Trends by Regions
2.2.1 Viral Vector Manufacturing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Viral Vector Manufacturing Historic Market Share by Regions (2016-2021)
2.2.3 Viral Vector Manufacturing Forecasted Market Size by Regions (2022-2027)
2.3 Viral Vector Manufacturing Industry Dynamic
2.3.1 Viral Vector Manufacturing Market Trends
2.3.2 Viral Vector Manufacturing Market Drivers
2.3.3 Viral Vector Manufacturing Market Challenges
2.3.4 Viral Vector Manufacturing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Manufacturing Players by Revenue
3.1.1 Global Top Viral Vector Manufacturing Players by Revenue (2016-2021)
3.1.2 Global Viral Vector Manufacturing Revenue Market Share by Players (2016-2021)
3.2 Global Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Viral Vector Manufacturing Revenue
3.4 Global Viral Vector Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vector Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing Revenue in 2020
3.5 Viral Vector Manufacturing Key Players Head office and Area Served
3.6 Key Players Viral Vector Manufacturing Product Solution and Service
3.7 Date of Enter into Viral Vector Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vector Manufacturing Breakdown Data by Type
4.1 Global Viral Vector Manufacturing Historic Market Size by Type (2016-2021)
4.2 Global Viral Vector Manufacturing Forecasted Market Size by Type (2022-2027)

5 Viral Vector Manufacturing Breakdown Data by Application
5.1 Global Viral Vector Manufacturing Historic Market Size by Application (2016-2021)
5.2 Global Viral Vector Manufacturing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Viral Vector Manufacturing Market Size (2016-2027)
6.2 North America Viral Vector Manufacturing Market Size by Type
6.2.1 North America Viral Vector Manufacturing Market Size by Type (2016-2021)
6.2.2 North America Viral Vector Manufacturing Market Size by Type (2022-2027)
6.2.3 North America Viral Vector Manufacturing Market Size by Type (2016-2027)
6.3 North America Viral Vector Manufacturing Market Size by Application
6.3.1 North America Viral Vector Manufacturing Market Size by Application (2016-2021)
6.3.2 North America Viral Vector Manufacturing Market Size by Application (2022-2027)
6.3.3 North America Viral Vector Manufacturing Market Size by Application (2016-2027)
6.4 North America Viral Vector Manufacturing Market Size by Country
6.4.1 North America Viral Vector Manufacturing Market Size by Country (2016-2021)
6.4.2 North America Viral Vector Manufacturing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Viral Vector Manufacturing Market Size (2016-2027)
7.2 Europe Viral Vector Manufacturing Market Size by Type
7.2.1 Europe Viral Vector Manufacturing Market Size by Type (2016-2021)
7.2.2 Europe Viral Vector Manufacturing Market Size by Type (2022-2027)
7.2.3 Europe Viral Vector Manufacturing Market Size by Type (2016-2027)
7.3 Europe Viral Vector Manufacturing Market Size by Application
7.3.1 Europe Viral Vector Manufacturing Market Size by Application (2016-2021)
7.3.2 Europe Viral Vector Manufacturing Market Size by Application (2022-2027)
7.3.3 Europe Viral Vector Manufacturing Market Size by Application (2016-2027)
7.4 Europe Viral Vector Manufacturing Market Size by Country
7.4.1 Europe Viral Vector Manufacturing Market Size by Country (2016-2021)
7.4.2 Europe Viral Vector Manufacturing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Manufacturing Market Size (2016-2027)
8.2 Asia-Pacific Viral Vector Manufacturing Market Size by Type
8.2.1 Asia-Pacific Viral Vector Manufacturing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Viral Vector Manufacturing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Viral Vector Manufacturing Market Size by Type (2016-2027)
8.3 Asia-Pacific Viral Vector Manufacturing Market Size by Application
8.3.1 Asia-Pacific Viral Vector Manufacturing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Viral Vector Manufacturing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Viral Vector Manufacturing Market Size by Application (2016-2027)
8.4 Asia-Pacific Viral Vector Manufacturing Market Size by Region
8.4.1 Asia-Pacific Viral Vector Manufacturing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Viral Vector Manufacturing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Viral Vector Manufacturing Market Size (2016-2027)
9.2 Latin America Viral Vector Manufacturing Market Size by Type
9.2.1 Latin America Viral Vector Manufacturing Market Size by Type (2016-2021)
9.2.2 Latin America Viral Vector Manufacturing Market Size by Type (2022-2027)
9.2.3 Latin America Viral Vector Manufacturing Market Size by Type (2016-2027)
9.3 Latin America Viral Vector Manufacturing Market Size by Application
9.3.1 Latin America Viral Vector Manufacturing Market Size by Application (2016-2021)
9.3.2 Latin America Viral Vector Manufacturing Market Size by Application (2022-2027)
9.3.3 Latin America Viral Vector Manufacturing Market Size by Application (2016-2027)
9.4 Latin America Viral Vector Manufacturing Market Size by Country
9.4.1 Latin America Viral Vector Manufacturing Market Size by Country (2016-2021)
9.4.2 Latin America Viral Vector Manufacturing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Manufacturing Market Size (2016-2027)
10.2 Middle East & Africa Viral Vector Manufacturing Market Size by Type
10.2.1 Middle East & Africa Viral Vector Manufacturing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Viral Vector Manufacturing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Viral Vector Manufacturing Market Size by Type (2016-2027)
10.3 Middle East & Africa Viral Vector Manufacturing Market Size by Application
10.3.1 Middle East & Africa Viral Vector Manufacturing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Viral Vector Manufacturing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Viral Vector Manufacturing Market Size by Application (2016-2027)
10.4 Middle East & Africa Viral Vector Manufacturing Market Size by Country
10.4.1 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Viral Vector Manufacturing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Details
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vector Manufacturing Introduction
11.1.4 BioReliance Revenue in Viral Vector Manufacturing Business (2016-2021)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Details
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vector Manufacturing Introduction
11.2.4 Cobra Biologics Revenue in Viral Vector Manufacturing Business (2016-2021)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Details
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vector Manufacturing Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2016-2021)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Details
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vector Manufacturing Introduction
11.4.4 UniQure Revenue in Viral Vector Manufacturing Business (2016-2021)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Details
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vector Manufacturing Introduction
11.5.4 FinVector Revenue in Viral Vector Manufacturing Business (2016-2021)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Details
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vector Manufacturing Introduction
11.6.4 MolMed Revenue in Viral Vector Manufacturing Business (2016-2021)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Details
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vector Manufacturing Introduction
11.7.4 MassBiologics Revenue in Viral Vector Manufacturing Business (2016-2021)
11.7.5 MassBiologics Recent Development
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Details
11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2016-2021)
11.8.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.9 Lonza
11.9.1 Lonza Company Details
11.9.2 Lonza Business Overview
11.9.3 Lonza Viral Vector Manufacturing Introduction
11.9.4 Lonza Revenue in Viral Vector Manufacturing Business (2016-2021)
11.9.5 Lonza Recent Development
11.10 Biovian
11.10.1 Biovian Company Details
11.10.2 Biovian Business Overview
11.10.3 Biovian Viral Vector Manufacturing Introduction
11.10.4 Biovian Revenue in Viral Vector Manufacturing Business (2016-2021)
11.10.5 Biovian Recent Development
11.11 Thermo Fisher Scientific (Brammer Bio)
11.11.1 Thermo Fisher Scientific (Brammer Bio) Company Details
11.11.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.11.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Introduction
11.11.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2016-2021)
11.11.5 Thermo Fisher Scientific (Brammer Bio) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Viral Vector Manufacturing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Adenoviral Vectors
Table 3. Key Players of Adeno-associated Viral Vectors
Table 4. Key Players of Retroviral Vectors
Table 5. Key Players of Lentiviral Vectors
Table 6. Key Players of Other
Table 7. Global Viral Vector Manufacturing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Viral Vector Manufacturing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Viral Vector Manufacturing Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Viral Vector Manufacturing Market Share by Regions (2016-2021)
Table 11. Global Viral Vector Manufacturing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Viral Vector Manufacturing Market Share by Regions (2022-2027)
Table 13. Viral Vector Manufacturing Market Trends
Table 14. Viral Vector Manufacturing Market Drivers
Table 15. Viral Vector Manufacturing Market Challenges
Table 16. Viral Vector Manufacturing Market Restraints
Table 17. Global Viral Vector Manufacturing Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Viral Vector Manufacturing Market Share by Players (2016-2021)
Table 19. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Manufacturing as of 2020)
Table 20. Ranking of Global Top Viral Vector Manufacturing Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Viral Vector Manufacturing Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Viral Vector Manufacturing Product Solution and Service
Table 24. Date of Enter into Viral Vector Manufacturing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Viral Vector Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Viral Vector Manufacturing Revenue Market Share by Type (2016-2021)
Table 28. Global Viral Vector Manufacturing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Viral Vector Manufacturing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Viral Vector Manufacturing Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Viral Vector Manufacturing Revenue Market Share by Application (2016-2021)
Table 32. Global Viral Vector Manufacturing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Viral Vector Manufacturing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Viral Vector Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Viral Vector Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Viral Vector Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Viral Vector Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Viral Vector Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Viral Vector Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Viral Vector Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Viral Vector Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Viral Vector Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Viral Vector Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Viral Vector Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Viral Vector Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Viral Vector Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Viral Vector Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Viral Vector Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Viral Vector Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Viral Vector Manufacturing Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Viral Vector Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Viral Vector Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Viral Vector Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Viral Vector Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Viral Vector Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Viral Vector Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Viral Vector Manufacturing Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Viral Vector Manufacturing Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Viral Vector Manufacturing Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Viral Vector Manufacturing Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Viral Vector Manufacturing Market Size by Country (2022-2027) & (US$ Million)
Table 64. BioReliance Company Details
Table 65. BioReliance Business Overview
Table 66. BioReliance Viral Vector Manufacturing Product
Table 67. BioReliance Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 68. BioReliance Recent Development
Table 69. Cobra Biologics Company Details
Table 70. Cobra Biologics Business Overview
Table 71. Cobra Biologics Viral Vector Manufacturing Product
Table 72. Cobra Biologics Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 73. Cobra Biologics Recent Development
Table 74. Oxford BioMedica Company Details
Table 75. Oxford BioMedica Business Overview
Table 76. Oxford BioMedica Viral Vector Manufacturing Product
Table 77. Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 78. Oxford BioMedica Recent Development
Table 79. UniQure Company Details
Table 80. UniQure Business Overview
Table 81. UniQure Viral Vector Manufacturing Product
Table 82. UniQure Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 83. UniQure Recent Development
Table 84. FinVector Company Details
Table 85. FinVector Business Overview
Table 86. FinVector Viral Vector Manufacturing Product
Table 87. FinVector Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 88. FinVector Recent Development
Table 89. MolMed Company Details
Table 90. MolMed Business Overview
Table 91. MolMed Viral Vector Manufacturing Product
Table 92. MolMed Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 93. MolMed Recent Development
Table 94. MassBiologics Company Details
Table 95. MassBiologics Business Overview
Table 96. MassBiologics Viral Vector Manufacturing Product
Table 97. MassBiologics Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 98. MassBiologics Recent Development
Table 99. FUJIFILM Diosynth Biotechnologies Company Details
Table 100. FUJIFILM Diosynth Biotechnologies Business Overview
Table 101. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 102. FUJIFILM Diosynth Biotechnologies Recent Development
Table 103. Lonza Company Details
Table 104. Lonza Business Overview
Table 105. Lonza Viral Vector Manufacturing Product
Table 106. Lonza Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 107. Lonza Recent Development
Table 108. Biovian Company Details
Table 109. Biovian Business Overview
Table 110. Biovian Viral Vector Manufacturing Product
Table 111. Biovian Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 112. Biovian Recent Development
Table 113. Thermo Fisher Scientific (Brammer Bio) Company Details
Table 114. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 115. Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Product
Table 116. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2016-2021) & (US$ Million)
Table 117. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vector Manufacturing Market Share by Type: 2020 VS 2027
Figure 2. Adenoviral Vectors Features
Figure 3. Adeno-associated Viral Vectors Features
Figure 4. Retroviral Vectors Features
Figure 5. Lentiviral Vectors Features
Figure 6. Other Features
Figure 7. Global Viral Vector Manufacturing Market Share by Application: 2020 VS 2027
Figure 8. Gene Therapy Case Studies
Figure 9. Vaccinology Case Studies
Figure 10. Viral Vector Manufacturing Report Years Considered
Figure 11. Global Viral Vector Manufacturing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Viral Vector Manufacturing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Viral Vector Manufacturing Market Share by Regions: 2020 VS 2027
Figure 14. Global Viral Vector Manufacturing Market Share by Regions (2022-2027)
Figure 15. Global Viral Vector Manufacturing Market Share by Players in 2020
Figure 16. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Manufacturing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing Revenue in 2020
Figure 18. Global Viral Vector Manufacturing Revenue Market Share by Type (2016-2021)
Figure 19. Global Viral Vector Manufacturing Revenue Market Share by Type (2022-2027)
Figure 20. North America Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Viral Vector Manufacturing Market Share by Type (2016-2027)
Figure 22. North America Viral Vector Manufacturing Market Share by Application (2016-2027)
Figure 23. North America Viral Vector Manufacturing Market Share by Country (2016-2027)
Figure 24. United States Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Viral Vector Manufacturing Market Share by Type (2016-2027)
Figure 28. Europe Viral Vector Manufacturing Market Share by Application (2016-2027)
Figure 29. Europe Viral Vector Manufacturing Market Share by Country (2016-2027)
Figure 30. Germany Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Viral Vector Manufacturing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Viral Vector Manufacturing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Viral Vector Manufacturing Market Share by Region (2016-2027)
Figure 40. China Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Viral Vector Manufacturing Market Share by Type (2016-2027)
Figure 48. Latin America Viral Vector Manufacturing Market Share by Application (2016-2027)
Figure 49. Latin America Viral Vector Manufacturing Market Share by Country (2016-2027)
Figure 50. Mexico Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Viral Vector Manufacturing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Viral Vector Manufacturing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Viral Vector Manufacturing Market Share by Country (2016-2027)
Figure 56. Turkey Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Viral Vector Manufacturing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. BioReliance Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 60. Cobra Biologics Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 61. Oxford BioMedica Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 62. UniQure Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 63. FinVector Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 64. MolMed Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 65. MassBiologics Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 66. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 67. Lonza Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 68. Biovian Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 69. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vector Manufacturing Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Global Viral Vector and Plasmid DNA Market Size, Status and Forecast 2021-2027
QYR2104Z5940 2021年4月 126Pages
QYResearch社発行の本調査資料では、ウイルスベクター＆プラスミドDNAのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プラスミドDNA、ウイルスベクター）、用途別市場規模（がん、ウイルス感染、遺伝性疾患）、主要地域別市場規模（北米、アメ...

世界のウイルスベクター＆プラスミドDNA製造市場規模・現状・予測（2021年-2027年）

Global Viral Vectors and Plasmid DNA Manufacturing Market Size, Status and Forecast 2021-2027
QYR2104Z5942 2021年4月 126Pages
QYResearch社発行の本調査資料では、ウイルスベクター＆プラスミドDNA製造のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プラスミドDNA、ウイルスベクター）、用途別市場規模（がん、遺伝性疾患、ウイルス感染症、その他）、主要地域別市場規...

世界のベクトル信号発生器市場規模・現状・予測（2021年-2027年）

Global Vector Signal Generator Market Size, Status and Forecast 2021-2027
QYR2104Z5869 2021年4月 97Pages
QYResearch社発行の本調査資料では、ベクトル信号発生器のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（2 GHzベクトル信号発生器、4 GHzベクトル信号発生器、6GHzベクトル信号発生器）、用途別市場規模（通信、電子機器、自動車、工業...

世界のアデノウイルスベクターワクチン市場規模・現状・予測（2021年-2027年）

Global Adenovirus Vector Vaccine Market Size, Status and Forecast 2021-2027
QYR2104Z0097 2021年4月 98Pages
QYResearch社発行の本調査資料では、アデノウイルスベクターワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（開発中、前臨床、臨床I、臨床II）、用途別市場規模（製薬・バイオテクノロジー企業、病院、学術・研究機関、その他）、主要地域...

世界のウイルス性結膜炎治療薬市場規模・現状・予測（2021年-2027年）

Global Viral Conjunctivitis Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z5938 2021年4月 94Pages
QYResearch社発行の本調査資料では、ウイルス性結膜炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（FST-100、APD-209）、用途別市場規模（病院、ASC、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の低周波ベクトルネットワークアナライザ（VNA）市場規模・現状・予測（2021年-2027年）

Global Low Frequency Vector Network Analyzer (VNA) Market Size, Status and Forecast 2021-2027
QYR2104Z3469 2021年4月 98Pages
QYResearch社発行の本調査資料では、低周波ベクトルネットワークアナライザ（VNA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（0-1.5GHz、1.5-8GHz、8-20GHz）、用途別市場規模（通信、航空宇宙・防衛、産業用自動車、...

世界のベクトル制御市場規模・現状・予測（2021年-2027年）

Global Vector Control Market Size, Status and Forecast 2021-2027
QYR2104Z5868 2021年4月 97Pages
QYResearch社発行の本調査資料では、ベクトル制御のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学、物理・機械、生物、その他）、用途別市場規模（商業用＆工業用、住宅用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界のウイルス性肝炎＆レトロウイルス診断検査市場規模・現状・予測（2021年-2027年）

Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Size, Status and Forecast 2021-2027
QYR2104Z5939 2021年4月 151Pages
QYResearch社発行の本調査資料では、ウイルス性肝炎＆レトロウイルス診断検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ウイルス性肝炎診断検査、レトロウイルス診断検査）、用途別市場規模（病院、診療所、訪問看護、その他）、主要地域別市場...

世界の細菌・ウイルス抗原市場規模・現状・予測（2021年-2027年）

Global Bacterial and Viral Antigens Market Size, Status and Forecast 2021-2027
QYR2104Z0687 2021年4月 96Pages
QYResearch社発行の本調査資料では、細菌・ウイルス抗原のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（不活化病原体、精製病原体）、用途別市場規模（病院・クリニック、診断研究所、学術・研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のインフルエンザウイルスベクターワクチン市場規模・現状・予測（2021年-2027年）

Global Influenza Virus Vector Vaccine Market Size, Status and Forecast 2021-2027
QYR2104Z3168 2021年4月 97Pages
QYResearch社発行の本調査資料では、インフルエンザウイルスベクターワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（開発中、前臨床、臨床I、臨床II）、用途別市場規模（製薬・バイオテクノロジー企業、病院、学術・研究機関、その他）、...

世界のウイルスベクター＆プラスミドDNA製造市場規模・現状・予測（2021年-2027年） The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases. Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers segment accoun…
世界の発現ベクター市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Expression Vectors Market The global Expression Vectors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
世界のウイルスベクター＆プラスミドDNA市場規模・現状・予測（2021年-2027年） Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory …
世界のウイルス性結膜炎治療薬市場規模・現状・予測（2021年-2027年） Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely t…
世界の細菌・ウイルス抗原市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bacterial and Viral Antigens Market The global Bacterial and Viral Antigens market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…